Llame gratis :
1 (855) MEDVIN-1
Psoriatic Arthritis Trial
Multiple studies available for this indication - criteria differs.
An FDA approved medication for Psoriasis is being investigated for the treatment for Psoriatic Arthritis (PsA). One injection every 3 months for 12 months. Psoriatic arthritis is a chronic inflammatory condition that affects the joints, causing pain, swelling, and stiffness. This study aims to evaluate the potential of new therapies in managing PsA symptoms and improving patient outcomes.
Trial Details
Criterios de participación
-
Must have a diagnosis of PsA for at least 6 months.
-
BMI over 27 (Obesity or Overweight)
-
Must have 3 tender, 3 swollen joints
-
Exclusion: Not qualified with a HX of Type 1 or 2 Diabetes
-
Exclusion: Have a prior or planned surgical treatment for obesity
Criterios de participación
-
Tujunga
-
Menifee
-
Riverside
-
Whittier
-
Apple Valley
-
Covina
-
Earn up to $1,470 (Up to $120-$150 per clinic visit), plus free Dietician Guidance/Consultations throughout the study.
Criterios de participación
-
FDA Approved medications: Taltz or Zepbound (weight loss drug). No placebo involved.
Criterios de participación
-
1 year study (12 office visits)
Criterios de participación
Psoriatic Arthritis Trial
Multiple studies available for this indication - criteria differs.
An FDA approved medication for Psoriasis is being investigated for the treatment for Psoriatic Arthritis (PsA). One injection every 3 months for 12 months. Psoriatic arthritis is a chronic inflammatory condition that affects the joints, causing pain, swelling, and stiffness. This study aims to evaluate the potential of new therapies in managing PsA symptoms and improving patient outcomes.
